Table 3.
*Total rats per grouping | Control (6) |
AFB1
(6) |
AFB1 + SBE-05-D1 (6) | AFB1 + SBE-05-D2 (6) |
AFB1 + SBE-06-D1 (6) |
AFB1 + SBE-06-D2 (6) |
AFB1 + SBE-07-D1 (6) |
AFB1 + SBE-07-D2 (6) |
---|---|---|---|---|---|---|---|---|
Sperm functional analysis | ||||||||
Motility | 93.00 ± 2.74 | 48.33 ± 2.58* | 65.00 ± 5.48 # | 67.50 ± 5.00 # | 68.33 ± 4.08 # | 62.00 ± 4.47 # | 61.67 ± 4.08 # | 56.67 ± 5.16 |
Viability | 95.80 ± 3.49 | 92.50 ± 2.74 | 96.50 ± 1.64 | 96.50 ± 1.72 | 96.50 ± 1.64 # | 96.80 ± 1.64 | 96.50 ± 1.64 | 96.50 ± 1.64 |
Testicular sperm count | 5.18 ± 0.04 | 4.92 ± 0.04* | 5.18 ± 0.04 # | 5.17 ± 0.05 # | 5.16 ± 0.05 # | 5.18 ± 0.04 # | 5.16 ± 0.05 # | 5.16 ± 0.05 # |
Epididymal sperm count | 116.60 ± 2.88 | 86.20 ± 8.14* | 98.83 ± 10.53 | 99.75 ± 8.88 | 99.17 ± 6.94 | 89.60 ± 11.80 | 92.83 ± 7.08 | 123.20 ± 5.31 # |
Sperm abnormalities | ||||||||
Abnormality of the head (%) | 2.22 ± 0.30 | 2.43 ± 0.48 | 2.30 ± 0.29 | 2.53 ± 0.45 | 2.27 ± 0.53 | 2.14 ± 0.40 | 2.35 ± 0.41 | 2.18 ± 0.29 |
Abnormality of the mid-piece (%) | 4.10 ± 0.39 | 6.20 ± 0.35* | 5.31 ± 0.39 # | 5.28 ± 0.41 | 5.41 ± 0.43 | 5.16 ± 0.18 # | 5.41 ± 0.35 | 5.65 ± 0.40 |
Abnormality of the tail (%) | 5.23 ± 0.49 | 6.67 ± 0.39* | 6.25 ± 0.53 | 6.25 ± 0.73 | 6.08 ± 0.27 | 5.97 ± 0.63 | 6.33 ± 0.52 | 6.36 ± 0.36 |
Total abnormality (%) | 116.60 ± 2.88 | 123.20 ± 5.30 | 98.83 ± 10.53 | 99.75 ± 8.88 | 99.17 ± 6.94 | 89.60 ± 11.80 | 92.83 ± 7.08 | 88.17 ± 8.72 |
AFB1: aflatoxin B1; SBE: Sorghum bicolor extract.
AFB1, 50 µg/kg; AFB1 + SBE-05-D1, 0.05 + 5 mg/kg; AFB1 + SBE-5-D2, 0.05 + 10 mg/kg; AFB1 + SBE-06-D1, 0.05 + 5 mg/kg; AFB1 + SBE-06-D2, 0.05 + 10 mg/kg; AFB1 + SBE-07-D1, 0.05 + 5 mg/kg; and AFB1 + SBE-07-D2, 0.05 + 10 mg/kg. Values are expressed as mean ± SD for six rats per group.
Values differ significantly from control (p < 0.05).
Values differ significantly from AFB1 alone (p < 0.05).